| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,007 |
796 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
408 |
338 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
466 |
399 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
281 |
215 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
797 |
345 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
202 |
119 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
299 |
250 |
$2K |
| 99497 |
|
30 |
24 |
$622.59 |
| 87807 |
|
37 |
29 |
$243.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
50 |
42 |
$240.55 |
| 92552 |
|
14 |
14 |
$163.57 |
| 96127 |
|
97 |
79 |
$160.60 |
| 96160 |
|
51 |
44 |
$92.92 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
14 |
$86.24 |
| 81025 |
|
32 |
30 |
$83.01 |
| 81003 |
|
62 |
53 |
$36.75 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
51 |
43 |
$15.96 |
| 3008F |
|
2,213 |
1,731 |
$0.02 |
| 2000F |
|
15 |
12 |
$0.00 |